- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.32 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 1 residues within 4Å:- Chain A: N.27
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.27
NAG.4: 1 residues within 4Å:- Chain A: N.290
No protein-ligand interaction detected (PLIP)NAG.9: 1 residues within 4Å:- Chain C: N.27
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.27
NAG.10: 1 residues within 4Å:- Chain C: N.290
No protein-ligand interaction detected (PLIP)NAG.15: 1 residues within 4Å:- Chain E: N.27
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.27
NAG.16: 1 residues within 4Å:- Chain E: N.290
No protein-ligand interaction detected (PLIP)- 3 x EZ7: N-[2-(2-{4-[(R)-(2-methyl-2H-tetrazol-5-yl)(phenyl)methyl]piperazine-1-carbonyl}pyridin-4-yl)-1,3-benzoxazol-5-yl]acetamide(Non-covalent)
EZ7.5: 17 residues within 4Å:- Chain A: H.12, H.32, Q.34, S.292, T.319
- Chain B: V.18, D.19, G.20, W.21, T.41, I.45, V.48, T.49, V.52, N.53, I.56
- Ligands: PEG.6
8 PLIP interactions:5 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:W.21, B:V.48, B:V.52, B:I.56
- Water bridges: B:N.53, A:A.33
- Hydrogen bonds: A:T.319
- pi-Stacking: A:H.12
EZ7.11: 17 residues within 4Å:- Chain C: H.12, H.32, Q.34, S.292, T.319
- Chain D: V.18, D.19, G.20, W.21, T.41, I.45, V.48, T.49, V.52, N.53, I.56
- Ligands: PEG.12
8 PLIP interactions:3 interactions with chain C, 5 interactions with chain D- Hydrogen bonds: C:T.319
- Water bridges: C:A.33, D:N.53
- pi-Stacking: C:H.12
- Hydrophobic interactions: D:W.21, D:V.48, D:V.52, D:I.56
EZ7.17: 17 residues within 4Å:- Chain E: H.12, H.32, Q.34, S.292, T.319
- Chain F: V.18, D.19, G.20, W.21, T.41, I.45, V.48, T.49, V.52, N.53, I.56
- Ligands: PEG.18
8 PLIP interactions:5 interactions with chain F, 3 interactions with chain E- Hydrophobic interactions: F:W.21, F:V.48, F:V.52, F:I.56
- Water bridges: F:N.53, E:A.33
- Hydrogen bonds: E:T.319
- pi-Stacking: E:H.12
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.6: 3 residues within 4Å:- Chain B: T.49, N.53
- Ligands: EZ7.5
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.53, B:N.53
PEG.12: 3 residues within 4Å:- Chain D: T.49, N.53
- Ligands: EZ7.11
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.53, D:N.53
PEG.18: 3 residues within 4Å:- Chain F: T.49, N.53
- Ligands: EZ7.17
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:N.53, F:N.53
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- van Dongen, M.J.P. et al., A small-molecule fusion inhibitor of influenza virus is orally active in mice. Science (2019)
- Release Date
- 2019-02-13
- Peptides
- Hemagglutinin: ACE
Hemagglutinin: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.32 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x EZ7: N-[2-(2-{4-[(R)-(2-methyl-2H-tetrazol-5-yl)(phenyl)methyl]piperazine-1-carbonyl}pyridin-4-yl)-1,3-benzoxazol-5-yl]acetamide(Non-covalent)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- van Dongen, M.J.P. et al., A small-molecule fusion inhibitor of influenza virus is orally active in mice. Science (2019)
- Release Date
- 2019-02-13
- Peptides
- Hemagglutinin: ACE
Hemagglutinin: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B